These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32891670)

  • 1. Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway.
    Camargo A; Dalmagro AP; de Souza MM; Zeni ALB; Rodrigues ALS
    Exp Neurol; 2020 Dec; 334():113459. PubMed ID: 32891670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling.
    Camargo A; Dalmagro AP; M Rosa J; B Zeni AL; P Kaster M; Tasca CI; S Rodrigues AL
    Neurochem Int; 2020 Oct; 139():104797. PubMed ID: 32652267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling.
    Camargo A; Dalmagro AP; Wolin IAV; Siteneski A; Zeni ALB; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110371. PubMed ID: 34089815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway.
    Camargo A; Dalmagro AP; Zeni ALB; Rodrigues ALS
    J Affect Disord; 2020 Jun; 271():100-108. PubMed ID: 32479304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice.
    Fraga DB; Camargo A; Olescowicz G; Azevedo Padilha D; Mina F; Budni J; Brocardo PS; Rodrigues ALS
    Chem Biol Interact; 2021 Jun; 342():109476. PubMed ID: 33872575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway.
    Camargo A; Dalmagro AP; Delanogare E; Fraga DB; Wolin IAV; Zeni ALB; Brocardo PS; Rodrigues ALS
    Eur Neuropsychopharmacol; 2022 Apr; 57():15-29. PubMed ID: 35008015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment.
    Camargo A; Torrá ACNC; Dalmagro AP; Valverde AP; Kouba BR; Fraga DB; Alves EC; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Apr; 115():110509. PubMed ID: 35033626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine.
    Neis VB; Bettio LB; Moretti M; Rosa PB; Olescowicz G; Fraga DB; Gonçalves FM; Freitas AE; Heinrich IA; Lopes MW; Leal RB; Rodrigues ALS
    Pharmacol Biochem Behav; 2018 Oct; 173():44-50. PubMed ID: 30125592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
    Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
    Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway.
    Camargo A; Dalmagro AP; Wolin IAV; Kaster MP; Rodrigues ALS
    J Psychiatr Res; 2021 Dec; 144():118-128. PubMed ID: 34619490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
    Pazini FL; Cunha MP; Rosa JM; Colla AR; Lieberknecht V; Oliveira Á; Rodrigues AL
    Mol Neurobiol; 2016 Dec; 53(10):6818-6834. PubMed ID: 26660117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway.
    Camargo A; Pazini FL; Rosa JM; Wolin IAV; Moretti M; Rosa PB; Neis VB; Rodrigues ALS
    J Psychiatr Res; 2019 Aug; 115():103-112. PubMed ID: 31128500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior.
    Brachman RA; McGowan JC; Perusini JN; Lim SC; Pham TH; Faye C; Gardier AM; Mendez-David I; David DJ; Hen R; Denny CA
    Biol Psychiatry; 2016 May; 79(9):776-786. PubMed ID: 26037911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single coadministration of subeffective doses of ascorbic acid and ketamine reverses the depressive-like behavior induced by chronic unpredictable stress in mice.
    Moretti M; Werle I; da Rosa PB; Neis VB; Platt N; Souza SVS; Rodrigues ALS
    Pharmacol Biochem Behav; 2019 Dec; 187():172800. PubMed ID: 31678791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice.
    Neis VB; Bettio LEB; Moretti M; Rosa PB; Ribeiro CM; Freitas AE; Gonçalves FM; Leal RB; Rodrigues ALS
    Pharmacol Biochem Behav; 2016; 150-151():108-114. PubMed ID: 27743829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecalciferol abolishes depressive-like behavior and hippocampal glucocorticoid receptor impairment induced by chronic corticosterone administration in mice.
    Camargo A; Dalmagro AP; Platt N; F Rosado A; B Neis V; B Zeni AL; P Kaster M; S Rodrigues AL
    Pharmacol Biochem Behav; 2020 Sep; 196():172971. PubMed ID: 32585162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway.
    Camargo A; Dalmagro AP; Fraga DB; Rosa JM; Zeni ALB; Kaster MP; Rodrigues ALS
    Psychopharmacology (Berl); 2021 Sep; 238(9):2555-2568. PubMed ID: 34342672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways.
    Rosa PB; Bettio LEB; Neis VB; Moretti M; Werle I; Leal RB; Rodrigues ALS
    Purinergic Signal; 2019 Dec; 15(4):491-504. PubMed ID: 31768875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling.
    Rosa PB; Bettio LEB; Neis VB; Moretti M; Kaufmann FN; Tavares MK; Werle I; Dalsenter Y; Platt N; Rosado AF; Fraga DB; Heinrich IA; Freitas AE; Leal RB; Rodrigues ALS
    Purinergic Signal; 2021 Jun; 17(2):285-301. PubMed ID: 33712981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agmatine potentiates antidepressant and synaptic actions of ketamine: Effects on dendritic arbors and spines architecture and Akt/S6 kinase signaling.
    Freitas AE; Heinrich IA; Moura TM; Fraga DB; Costa AP; Azevedo D; Brocardo PS; Kaster MP; Leal RB; Rodrigues ALS
    Exp Neurol; 2020 Nov; 333():113398. PubMed ID: 32659382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.